South Korea Prefilled Syringes Market (2026-2031)
The South Korea Prefilled Syringes Market was valued at $136 Million in 2026 and projected to reach to $213.1 Million by 2031, representing a compound annual growth rate of 9.4%. South Korea's prefilled syringes market is positioned for sustained growth through 2031, supported by an aging population increasingly requiring chronic disease management and injectable therapies.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
South Korea Prefilled Syringes Market Trends and Insights
- This 9.4% compound annual growth rate reflects South Korea's advancing healthcare infrastructure and increasing adoption of injectable biologics and specialty pharmaceuticals.
- South Korea's aging population and rising prevalence of chronic diseases are driving demand for convenient, pre-filled delivery systems that enhance patient compliance and reduce medication errors. The South Korea prefilled syringes market benefits from the country's strong pharmaceutical manufacturing capabilities and regulatory support for innovative drug delivery solutions.
- South Korea's healthcare system prioritizes patient safety and operational efficiency, making prefilled syringes an attractive option for hospitals, clinics, and home-care settings.
- Between 2026 and 2031, South Korea is expected to see increased investment in biologics production and personalized medicine, further accelerating market penetration across therapeutic areas including oncology, immunology, and diabetes management..
Key Market Statistics
- CAGR (2026-2031) 9.4% CAGR
- Market Size, 2026 ~USD 136 Million
- Forecast, 2031 ~USD 213.1 Million
- Country South Korea
South Korea Prefilled Syringes Market Overview
Market Valuation Growth :
South Korea's prefilled syringes market is valued at $136.0 million in 2026, expanding to $213.1 million by 2031, representing a robust 9.4% CAGR driven by healthcare modernization and pharmaceutical innovation.
Aging Population Impact :
South Korea's rapidly aging demographic is accelerating demand for injectable treatments, chronic disease management solutions, and self-administration devices that prefilled syringes provide.
Biologic Drug Adoption :
Increasing adoption of injectable biologics, monoclonal antibodies, and specialty pharmaceuticals in South Korea is driving prefilled syringe utilization across oncology, immunology, and rheumatology segments.
Healthcare Infrastructure Advancement :
South Korea's advanced healthcare system, high digital penetration, and strong regulatory framework support rapid adoption of innovative drug delivery systems and prefilled syringe technologies.
South Korea Prefilled Syringes Market Dynamics
- The country's sophisticated healthcare infrastructure and strong pharmaceutical sector create favorable conditions for adoption of advanced drug delivery systems.
- Rising healthcare expenditure and government initiatives promoting preventive care further bolster market expansion.
- Additionally, South Korea's biopharmaceutical industry growth and increasing clinical adoption of biologics will continue driving prefilled syringe demand across hospitals, clinics, and home healthcare settings..
Related Ecosystem
Key Takeaways
- South Korea's prefilled syringes market is valued at $136.0 million in 2026 and is projected to reach $213.1 million by 2031, representing a 9.4% CAGR.
- South Korea's aging demographic and rising chronic disease burden are primary drivers of prefilled syringe adoption across healthcare settings.
- South Korea's robust pharmaceutical manufacturing ecosystem and regulatory framework support innovation in drug delivery technologies.
- South Korea's healthcare system emphasis on patient safety and medication accuracy is accelerating prefilled syringe uptake in clinical and home-care environments.
Prefilled Syringes Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SAFETY PREFILLED SYRINGES (Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 10.9% from 2026 to 2031 |
| Largest Segment | CONVENTIONAL PREFILLED SYRINGES (Type) |
| Market Size Base Year (Billions) | ~USD 8.66 (2026) |
| Revenue Forecast (Billions) | ~USD 14.53 (2031) |
| Segments Covered | Type, Design, Material, Application |
South Korea Prefilled Syringes Market Report Segmentation
4 segment dimensions are covered across the global market.
By Type
- Conventional Prefilled Syringes
- Disposable Prefilled Syringes
- Reusable Prefilled Syringes
- Safety Prefilled Syringes
By Design
- Customized Prefilled Syringes
- Dual-Chamber Prefilled Syringes
- Single-Chamber Prefilled Syringes
By Material
- Glass Prefilled Syringes
- Plastic Prefilled Syringes
By Application
- Anaphylaxis
- Cancer
- Diabetes
- Ophthalmology
- Other Applications
- Rheumatoid Arthritis
- Thrombosis
Target Audience
- Pharmaceutical & Biopharmaceutical Companies : Manufacturers and developers of injectable drugs need South Korea market data to assess market opportunity, plan product launches, and optimize prefilled syringe adoption strategies in this growing biologic market.
- Medical Device Manufacturers : Prefilled syringe and drug delivery device producers require country-specific insights to identify market gaps, competitive positioning, and regulatory requirements for South Korea's healthcare sector.
- Healthcare System Administrators : Hospital networks, clinics, and healthcare providers need market intelligence to understand prefilled syringe adoption trends, procurement strategies, and cost-benefit analysis for South Korea's patient populations.
- Investment & Private Equity Firms : Investors evaluating healthcare opportunities in South Korea require detailed market sizing and growth projections to assess portfolio companies, identify acquisition targets, and evaluate sector valuations.
- Market Research & Consulting Professionals : Analysts and consultants serving healthcare clients need granular South Korea market data to support client advisory work, competitive benchmarking, and strategic recommendations in the injectable drug delivery space.
Key Companies in the South Korea Prefilled Syringes Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ATS AUTOMATION TOOLING SYSTEMS INC | Canada | Public Company | Conventional prefilled syringe automation,Safety prefilled syringe automation,Glass prefilled syringe–focused systems, |
| CONSORT MEDICAL | United Kingdom | Private Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| HENRY SCHEIN | United States | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
| FLUOR CORPORATION | United States | Public Company | Conventional Prefilled Syringe Infrastructure,Safety Prefilled Syringe Infrastructure,Glass Prefilled Syringe Facilities, |
| MERIT MEDICAL | United States | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
| GUERBET GROUP | France | InvalidIdentifier | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| BECTON, DICKINSON AND COMPANY (BD) | United States | ||
| GERRESHEIMER AG | Germany | Public Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| SCHOTT | Germany | Public Company | Glass prefilled syringes (syriQ, syriQ BioPure, silicone-free),Polymer prefilled syringes (TOPPAC portfolio),Cartridges (cartriQ, dual-chamber, large volume), |
| WEST PHARMACEUTICAL SERVICES, INC. | United States | Public Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringe containment and components, |
| APTARGROUP, INC. | United States | Public Company | Conventional prefilled syringe components,Safety prefilled syringe and device-integrated systems,Glass prefilled syringe-related solutions, |
| NIPRO | Japan | Public Company | Glass Prefilled Syringe,Plastic Prefilled Syringe,Conventional Prefilled Syringe, |
| NOVARTIS AG | Switzerland | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringe, |
| STEVANATO GROUP | Italy | Public Company | Conventional prefilled syringes,Safety prefilled syringes,Glass prefilled syringes, |
| POLYMEDICURE | India | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
| SHARPS TECHNOLOGY, INC. | United States | Public Company | Conventional Prefilled Syringes,Safety Prefilled Syringes,Glass Prefilled Syringes, |
ATS AUTOMATION TOOLING SYSTEMS INC
ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems for industrial applications.
CONSORT MEDICAL
Consort Medical is a United Kingdom-based private company established in 1938 with 2,000 employees. The company operates in the medical devices and pharmaceutical sectors.
HENRY SCHEIN
Henry Schein is a United States public company founded in 1932 with 25,000 employees. The company is a distributor of healthcare products and services to dental, medical, and veterinary markets.
FLUOR CORPORATION
Fluor Corporation is a United States public company founded in 1912 with 22,995 employees. The company provides engineering, procurement, and construction services to the energy, chemicals, and infrastructure sectors.
MERIT MEDICAL
Merit Medical is a United States public company founded in 1987 with 7,500 employees. The company designs, manufactures, and distributes medical devices for interventional medicine and vascular access.
GUERBET GROUP
Guerbet Group is a French company in the medical imaging and pharmaceutical sectors. Specific operational details are unavailable.
BECTON, DICKINSON AND COMPANY (BD)
Becton, Dickinson and Company (BD) is a United States-based medical technology company. Specific founding date and employee count details are unavailable.
GERRESHEIMER AG
Gerresheimer AG is a German public company founded in 1864 with 13,528 employees. The company manufactures specialty glass and plastic products for the pharmaceutical and healthcare industries.
SCHOTT
Schott is a German public company founded in 1884 with 4,839 employees. The company produces specialty glass and glass-ceramic products for pharmaceutical, laboratory, and industrial applications.
WEST PHARMACEUTICAL SERVICES, INC.
West Pharmaceutical Services, Inc. is a United States public company founded in 1923 with 10,800 employees. The company manufactures packaging and delivery systems for injectable drugs and healthcare products.
APTARGROUP, INC.
AptarGroup, Inc. is a United States public company founded in 1992 with 14,000 employees. The company designs and manufactures dispensing systems and closures for the pharmaceutical, beauty, and food industries.
NIPRO
Nipro is a Japanese public company founded in 1947 with 38,593 employees. The company manufactures and distributes medical devices, pharmaceuticals, and healthcare products globally.
NOVARTIS AG
Novartis AG is a Swiss public company founded in 1996 with 75,267 employees. The company is a global pharmaceutical and healthcare company developing innovative medicines and treatments.
STEVANATO GROUP
Stevanato Group is an Italian public company founded in 1949 with 6,010 employees. The company manufactures glass and plastic packaging solutions for the pharmaceutical industry.
POLYMEDICURE
Polymedicure is an Indian public company founded in 1995 with 3,082 employees. The company manufactures and distributes medical devices and healthcare products.
SHARPS TECHNOLOGY, INC.
Sharps Technology, Inc. is a United States public company founded in 2017. Specific employee count details are unavailable.
Reasons to Buy this Report
- Market-Specific Sizing & Forecasts : Access precise valuation data for South Korea's prefilled syringes market with detailed 2026-2031 projections, enabling accurate financial planning and investment decisions tailored to this high-growth Asian market.
- Demographic & Clinical Insights : Understand South Korea's unique aging population dynamics and chronic disease prevalence driving injectable therapy adoption, with analysis of therapeutic segments most impacted by demographic shifts.
- Competitive Landscape Intelligence : Identify key market players, regulatory pathways, and competitive positioning specific to South Korea's healthcare system, supporting strategic market entry and partnership development.
- Growth Driver Analysis : Evaluate South Korea-specific growth catalysts including biopharmaceutical innovation, healthcare infrastructure investments, and government healthcare policies shaping prefilled syringe market expansion.
- Strategic Business Planning : Leverage country-specific market intelligence to develop targeted go-to-market strategies, pricing models, and distribution approaches optimized for South Korea's healthcare ecosystem and regulatory environment.
Frequently asked questions
What is the current market size of prefilled syringes in South Korea?
South Korea's prefilled syringes market was valued at $136.0 million in 2026 and is expected to grow to $213.1 million by 2031.
What is the projected growth rate for South Korea's prefilled syringes market?
South Korea's prefilled syringes market is projected to grow at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2031.
What factors are driving growth in South Korea's prefilled syringes market?
South Korea's prefilled syringes market growth is driven by an aging population, rising chronic disease prevalence, strong pharmaceutical manufacturing capabilities, and healthcare system emphasis on patient safety and medication accuracy.
Which therapeutic areas are adopting prefilled syringes most rapidly in South Korea?
South Korea is seeing accelerated prefilled syringe adoption in oncology, immunology, and diabetes management, supported by increased investment in biologics production and personalized medicine.
How does South Korea's regulatory environment support the prefilled syringes market?
South Korea's regulatory framework actively supports innovation in drug delivery solutions, enabling manufacturers to develop and commercialize advanced prefilled syringe technologies that meet stringent safety and efficacy standards.
RESEARCH METHODOLOGY
This study involved four major activities in estimating the current prefilled syringes market size. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments
Secondary Research
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the prefilled syringes market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the prefilled syringes market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.
A breakdown of the primary respondents for the prefilled syringes market is provided below:
**Others include sales, marketing, and product managers.
Note 1: C-level executives include CEOs, COOs, and CTOs.
Note 2: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the prefilled syringes market includes the following details.
The market sizing of the market was undertaken from the global side.
Country-level Analysis: The size of the prefilled syringes market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products and services in the overall prefilled syringes market was obtained from secondary data and validated by primary participants to arrive at the total prefilled syringes market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by prefilled syringes and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall prefilled syringes market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Prefilled Syringes Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Prefilled syringes are a convenient way to deliver parenteral medications or a single-dose packet of medication with a premeasured dose. This method of drug administration offers advantages for manufacturers in terms of reducing drug waste and extending product lifespan. Additionally, it provides ease of self-administration for patients at home and in non-hospital settings. Some examples of drugs packaged in prefilled syringes include biologics, vaccines, blood stimulants, therapeutic proteins, erythropoietin products, and interferons.
Key Stakeholders
- Product manufacturers, distributors, and suppliers
- Research laboratories
- Academic universities and medical research centers
- R&D centers
- Business research and consulting firms
- Biotechnology companies
- Hospitals
- Clinical centers
- Pharmaceutical companies
- Medical research laboratories
- Consulting firms
Report Objectives
- To describe, analyze, and forecast the prefilled syringes market by type, design, material, application, and region
- To describe and forecast the prefilled syringes market for key regions—North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the prefilled syringes market
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the prefilled syringes market
- To analyze competitive developments such as partnerships, collaborations, agreements & acquisitions, product launches, expansions, and R&D activities in the prefilled syringes market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
- Further breakdown of the Rest of Europe prefilled syringes market into Belgium, Russia, the Netherlands, Switzerland, and other countries.
- Further breakdown of the Rest of Asia Pacific prefilled syringes market into Indonesia, Philippines, Vietnam, Hong Kong, and other countries
- Further breakdown of the Rest of Latin America prefilled syringes market into Colombia, Peru, and other countries.
Get the Full Prefilled Syringes Market Report
Full forecast, segment splits, and company analysis for all Prefilled Syringes Market.
- Canada Prefilled Syringes Market
- US Prefilled Syringes Market
- Germany Prefilled Syringes Market
- UK Prefilled Syringes Market
- France Prefilled Syringes Market
- Spain Prefilled Syringes Market
- Italy Prefilled Syringes Market
- Japan Prefilled Syringes Market
- China Prefilled Syringes Market
- India Prefilled Syringes Market
- Australia Prefilled Syringes Market
- Brazil Prefilled Syringes Market
- Mexico Prefilled Syringes Market
- Argentina Prefilled Syringes Market
- GCC Countries Prefilled Syringes Market
- Rest Of Europe Prefilled Syringes Market
- Rest Of Asia Pacific Prefilled Syringes Market
- Rest Of Latin America Prefilled Syringes Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report